Ronald A. Pepin's most recent trade in Celldex Therapeutics Inc. was a trade of 20,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Celldex Therapeutics Inc. | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,000 | 20,000 | - | - | Incentive Stock Option (right to buy) | |
Celldex Therapeutics Inc. | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 15,000 | 15,000 | - | - | Incentive Stock Option (right to buy) | |
Celldex Therapeutics Inc. | Ronald A. Pepin | SR. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,000 | 15,000 | - | - | Incentive Stock Option (right to buy) | |
Celldex Therapeutics Inc. | Ronald A. Pepin | Sr. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,500 | 15,500 | - | - | Incentive Stock Option (right to buy) | |
Celldex Therapeutics Inc. | Ronald A. Pepin | Sr. VP & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 14,400 | 14,400 | - | - | Incentive Stock Option (right to buy) |